Spirulina, Chlorella, MCP & Modified Alginate Complex for Heavy Metal Detoxification - Quick Reference Sheet
evipedia.aidev
← Back

Spirulina, Chlorella, MCP & Modified Alginate Complex for Heavy Metal Detoxification

Created on 08/13/2026 – Quick Reference based on Evidence Review created using AI4L / Grok 4.5 – Audit

This combination is four oral fibers and algae used together as a milder alternative to prescription metal-binding drugs. Alginate can block uptake of newly swallowed metals. The metal-removal claim is still thinly tested. Some algae products carry lead and blue-green-algae toxins. Blood-pressure, cholesterol, weight, and nasal-allergy shifts from the algae are better quantified but modest. (Full Review)

Protocol

Integrative Eliaz-style regimen
PectaSol-C 5 g three times daily
Away from food; modified alginate 1.5–3 g with meals; chlorella 2–5 g/day; spirulina 1–3 g/day
Time of day
MCP between meals
Alginate, chlorella, and spirulina with meals for lumen binding; spirulina earlier in the day if sleep is light
Single versus split doses
Split MCP three times daily
Split alginate with each major meal; algae once or twice daily with food
Time to effect
Blood pressure
About eight weeks
Algae meta-analyses; modest vascular bonus, not metal-removal proof
Lipids
About eight weeks
Algae meta-analyses
Urinary metal shifts
One to six days
MCP pilots; a urine-metal rise is not a demonstrated fall in body burden

Benefits

Contraindications
  • Phenylketonuria or other disorders requiring strict phenylalanine restriction (spirulina protein)
  • Active autoimmune skin or connective-tissue disease (dermatomyositis; cutaneous lupus), especially if previously flared by immune-support algae
  • Documented allergy to algae, seaweed, or citrus pectin
  • Infants and young children using untested algae powders (lead and microcystin risk)
  • Pregnancy when the algae source is not independently tested for metals and microcystins
  • eGFR below 45 mL/min/1.73 m² when high-dose binders are used to mobilize metals
  • Unmonitored warfarin anticoagulation if adding vitamin K–rich chlorella
    •
Key Interactions
  • Vitamin K–antagonist anticoagulants (warfarin)
  • CYP1A2 substrates (theophylline, tizanidine, clozapine, duloxetine)
  • Immunosuppressants (tacrolimus, mycophenolate, high-dose corticosteroids)
  • Antihypertensives (amlodipine, lisinopril, losartan)
  • Thyroid hormone (levothyroxine) and iodine-sensitive thyroid disease
  • Other oral drugs and supplements (levothyroxine, antibiotics, fat-soluble vitamins, minerals)
  • Additive metal-binding agents (activated charcoal, cholestyramine, sucralfate, succimer, calcium disodium EDTA)
  • Hypotensive or hypoglycemic combinations (high-dose magnesium, berberine)
    •

Risk & Side Effects

  • High: Heavy-metal and cyanotoxin contamination of algae products
    •
  • Medium: Gastrointestinal intolerance; Autoimmune flare from immunostimulatory algae
    •
  • Low: Isolated hepatotoxicity reports; Immediate allergy, including anaphylaxis; Binding of essential minerals by alginate
    •
  • Speculative: Redistribution of metals without net clearance; Chronic exposure to β-methylamino-L-alanine or residual iodine
    •

Monitoring

Marker Target Why
Blood lead <1.0 µg/dL (functional); many labs still flag only ≥3.5 µg/dL Confirms whether MCP-style excretion changed the circulating pool
Blood mercury, total <1–2 µg/L functional; many labs accept <5–10 µg/L Tracks methylmercury from fish versus inorganic sources
Urine arsenic, speciated Inorganic arsenic plus metabolites as low as feasible; often <10 µg/g creatinine Separates toxic arsenic from harmless seafood arsenobetaine
Blood cadmium As low as feasible; often <0.5 µg/L Cadmium half-life is decades; change is slow
Serum ferritin 50–150 ng/mL (context-dependent) Low iron raises lead and cadmium absorption
Plasma zinc 90–130 µg/dL Low zinc raises metal uptake and may fall if alginate binds cations
Serum calcium and 25-hydroxy vitamin D Calcium in mid-lab range; 25-OHD about 40–60 ng/mL Alginate can trim calcium absorption
TSH 0.5–2.5 mIU/L functional vs broader lab 0.4–4.5 Tracks iodine load from seaweed alginate
Serum creatinine / eGFR eGFR ≥60 mL/min/1.73 m² before mobilizing doses Mobilized metal leaves via kidney
ALT Inside lab range, no rise from baseline Rare spirulina-associated liver injury
INR In the individual’s warfarin target Chlorella vitamin K can shift anticoagulation
Galectin-3 No established functional target; track change from own baseline if MCP is used for fibrosis biology Independent MCP hypertension trial did not move collagen markers

Cadence: Unprovoked metal, mineral, and safety panel before the first full dose; again at four weeks, at the end of an eight- to twelve-week course, then every three to six months if algae continue as food

Qualitative Assessment

  • Gastrointestinal comfort, stool frequency, and unexpected green stool
  • Energy, exercise recovery, and afternoon fatigue
  • Cognitive clarity and metallic taste
  • New rash, muscle pain, or autoimmune-type symptoms
  • Orthostatic lightheadedness after algae are added to blood-pressure drugs
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.